JLABS

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Until recently, innovation lay dormant in the quality-driven cannabis industry. However, an evolving regulatory environment, coupled with...

Health Canada has granted biopharmaceutical researcher and cannabis producer Avicanna Inc (TSX: AVCN) with a research license that will allow the company to perform research and intellectual property development on cannabinoids at its facility in the MaRS Discovery District in Toronto. The...

Investors may soon have the opportunity to invest in a new cannabis company. Avicanna, a Canadian cannabinoid-focused company, has filed a preliminary prospectus to go public in Canada. The company plans to apply for its listing on the Canadian Securities Exchange. About Avicanna Avicanna focuses...

Shares of GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) were halted Thursday, ahead of a Food and Drug Administration vote on the company's cannabis-derived drug Epidiolex. Trading resumed after the FDA advisory panel voted unanimously in favor of approving the medicine for the treatment of two...

As a cannabis-focused company, Avicanna did not know what the outcome would be when it applied to be part of JLABS @ Toronto. Yet, the company was delighted to make it, CEO Aras Azadian and LATAM Vice President Lucas Nosiglia told Benzinga in a recent interview. A few things became clear early in...